Korro Bio (KRRO) EBT (2018 - 2026)
Korro Bio (KRRO) posted EBT of -$19.5 million for Q1 2026, down 128.55% on a QoQ basis from $68.4 million in Q4 2025, and up 16.49% year-over-year from -$16.8 million in Q1 2025.
Korro Bio (KRRO) EBT (2018 - 2026) Analysis & Trends
Korro Bio's EBT history runs 9 years deep, the most recent figure standing at -$19.5 million for Q1 2026.
- Quarterly EBT rose 16.49% year-over-year to -$19.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 233.35% YoY) and the FY2025 annual result came in at $1.2 million, up 1888.33% from the prior year.
- EBT was -$19.5 million for Q1 2026 at Korro Bio, down from $68.4 million in the prior quarter.
- Across five years, EBT topped out at $68.4 million in Q4 2025 and bottomed at -$25.8 million in Q2 2025.
- A 5-year average of -$9.3 million and a median of -$19.6 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2023 — EBT tumbled 509.77% — and 2024, when it soared 345.43%.
- Korro Bio's EBT stood at $6.2 million in 2022, then tumbled by 509.77% to -$25.4 million in 2023, then surged by 345.43% to $62.4 million in 2024, then gained by 9.62% to $68.4 million in 2025, then slumped by 128.55% to -$19.5 million in 2026.
- Business Quant data shows KRRO's EBT at -$19.5 million in Q1 2026, $68.4 million in Q4 2025, and -$18.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 221.65 Mn |
| 10 | Korro Bio | 120.63 Mn | 6.66 Mn | - | -19.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.53 Mn |
| Dec 31, 2025 | 68.41 Mn |
| Sep 30, 2025 | -18.06 Mn |
| Jun 30, 2025 | -25.77 Mn |
| Mar 31, 2025 | -23.39 Mn |
| Dec 31, 2024 | 62.40 Mn |
| Sep 30, 2024 | -21.01 Mn |
| Jun 30, 2024 | -21.80 Mn |
| Mar 31, 2024 | -19.54 Mn |
| Dec 31, 2023 | -25.43 Mn |
| Sep 30, 2023 | -18.49 Mn |
| Jun 30, 2023 | -17.62 Mn |
| Mar 31, 2023 | -19.61 Mn |
| Dec 31, 2022 | 6.21 Mn |
| Sep 30, 2022 | -19.57 Mn |
| Jun 30, 2022 | -21.28 Mn |
| Mar 31, 2022 | -23.37 Mn |
| Dec 31, 2021 | -21.50 Mn |
| Sep 30, 2021 | -25.15 Mn |
| Jun 30, 2021 | -17.65 Mn |